Screener
Oruka Therapeutics, Inc. ORKA Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxCreditsResearch.
The source filing: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026.
- Filed
- Mar 12, 2026, 4:03 PM EDT
- Fiscal year
- FY2025
- Accession
- 0001213900-26-026929
| Line item | Year Ended December 31, 2025 / Amount | Year Ended December 31, 2025 / Percent | Period from February 6, 2024 (inception) to December 31, 2024 / Amount | Period from February 6, 2024 (inception) to December 31, 2024 / Percent |
|---|---|---|---|---|
| Tax benefit derived by applying the federal statutory rate to loss before income taxes | $(22,141) | (21.00 | $(17,582) | (21.00 |
| Nontaxable or nondeductible items | 54 | 0.05 | 76 | 0.09 |
| Credits | ||||
| Research and development credits | (2,109) | (2.00) | (2,840) | (3.39) |
| Other | 949 | 0.90 | (731) | (0.87) |
| Worldwide changes in unrecognized tax benefits | (91) | (0.09) | — | 0.00 |
| Change in the valuation allowance | 23,338 | 22.14 | 21,077 | 25.17 |
| Income tax (benefit) expense | — | 0.00% | — | 0.00% |
Item 8. Financial Statements and Supplementary
FAQ
- What is Oruka Therapeutics, Inc.'s effective income tax rate reconciliation, tax credit, research, amount?
- Oruka Therapeutics, Inc. (ORKA) reported effective income tax rate reconciliation, tax credit, research, amount of $527.25K in Q4 2025.
- How has Oruka Therapeutics, Inc.'s effective income tax rate reconciliation, tax credit, research, amount changed year-over-year?
- Oruka Therapeutics, Inc.'s effective income tax rate reconciliation, tax credit, research, amount decreased by 81.4% year-over-year, from $2.84M to $527.25K.
- What does effective income tax rate reconciliation, tax credit, research, amount mean?
- This represents the dollar amount of tax benefits derived from research and development tax credits applied against the statutory income tax rate. It highlights the company's ability to reduce its tax liability through innovation-related incentives.
Ask your AI about Oruka Therapeutics, Inc.'s effective income tax rate reconciliation, tax credit, research, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude